Beth Devine

Emily Elizabeth Devine

My passion for the multidisciplinary field of health economics and outcomes research is motivated by my desire to ensure that we, as scientists, provide the best value for investments made – for our individual patients, for populations under our care, and for the health(care) sector of society.

I am particularly passionate about applying the most rigorous and appropriate study designs and analytic methods to accurately answer relevant questions in the areas of evidence synthesis, comparative effectiveness of health technologies, precision medicine in the context of clinical informatics, and patient centered outcomes. To do so, I employ methods at the intersection of evidence synthesis and decision modeling.

I am also passionate about training the next generation of scientists in Health Economics and Outcomes Research

Biography

Research Program Summary

Selected Honors and Awards

Useful Links

Download My Detailed CV

Biography

I am Professor Emeritus at The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, School of Pharmacy, University of Washington (UW), where I held the Shirley and Herb Bridge Endowed Professor for Women in Pharmacy from 2021 to 2023. I am a member of the UW Institute for Public Health Genetics and the Plein Center for Aging.

I am currently a Visiting Professor at the University of Bristol, UK (2024-2026).

I have been an Honorary Professor (2022-2023), and a Visiting Professor (2022) in the Department of Epidemiology, Public Health & Health Services, School of Medicine, University of Murcia, Spain.

Beth Devine Biography: Universidad de Murcia

I had the privilege of being a Fulbright US Scholar to Murcia (2021).

I am president-elect of ISPOR – The Professional Society for Health Economics and Outcomes Research (2025-2026), was a member of the Board of Directors of ISPOR (2021-2024) and am Associate Editor for the ISPOR journal Value in Health (2021-2029). I served on the ISPOR Task Force that developed guidelines to conduct network meta-analyses (2009-2011) and am co-chairing the ISPOR Task Force to update to these guidelines (2026).

From 2014-2025 I served as an Assistant Director of the AHRQ-funded Pacific Northwest Evidence-based Practice Center.

In 2013, I was elected as a member of the Society for Research Synthesis Methodology.

Prior to joining the faculty at the UW, I was an advanced practice (prescribing) clinical pharmacist and led the Pharmacy & Therapeutics Committee at the University of California San Francisco. This is where I developed my passion for health technology assessment and health economics and outcomes research.

Beth Devine Biography: University of California San Francisco

I served a term as president of the California Society of Health-System Pharmacists, earning their Lifetime Achievement Award for my leadership role in advancing the scope of practice for California pharmacists through legislation (1994).

Biogaphy

Research Program Summary

Health economics and outcomes research is a multidisciplinary field that employs methods from the overlapping disciplines of epidemiology, biostatistics, decision sciences, health economics and health policy. Trained in these fields, my research portfolio can be summarized by the following support and recent publications.

1. Evidence synthesis:, systematic reviews; network meta-analyses and meta-analyses in Bayesian and frequentist frameworks. (total n=68)

Support: AHRQ Evidence-based Practice Center Methods Group, NIH/National Institute of Aging, NIH/National Heart Lung and Blood Institute, US Fulbright Program, UW Innovation Gap Fund (CoMotion), UW School of Pharmacy, Health Technology Fund, ISPOR-Professional Society for Health Economics and Outcomes Research

Devine B, Welton NJ, Higgins JPT. The impact on results when causal inference studies and bias-adjustment procedures are incorporated into network meta-analyses of randomized controlled trials. (manuscript in preparation)

Li K, Brandling-Bennett H, Luong J, Devine B. Indirect Treatment Comparison of Biologic Treatments in Adolescents with Moderate to Severe Atopic Dermatitis: A Systematic Literature Review and Network Meta Analysis. (in press at Ann Pharmacother, December 2025)

Whiting P, Wolff R, Savović J, Devine B, Mallett S. Introducing the LATITUDES Network: a Library of Assessment Tools and training to Improve Transparency, Utility and Dissemination in Evidence Synthesis. 2024 Jul 30:174:111486. PMID: 39084579. doi: 10.1016/j.jclinepi.2024.111486.

Chua S, , Todd A, Huang Y, Hughes S, Elsisi Z, Husband A, Gray SL, Devine B and members of the US Deprescribing Network Systematic Review Panel. Effectiveness of deprescribing interventions in older adults: An overview of systematic reviews. PLoS One. 2024 Jun 17;19(6):e0305215. PMID: 38885276.doi: 10.1371/journal.pone.0305215. eCollection 2024.

Bloudek L, Wright P, McKay C, Derleth CL, Lill JS, Lenero E, Hepp Z, Ramsey SD, Sullivan SD, Devine B. Systematic Literature Review (SLR) and Network Meta-Analysis (NMA) of First-Line Therapies (1L) for Locally Advanced/Metastatic Urothelial Carcinoma (la/mUC). Curr Oncol. 2023 Mar 26;30(4):3637-3647. doi: 10.3390/curroncol30040277.PMID: 37185390

Dhippayom T, Devine B. Reply to Assessing safety and efficacy in a network meta-analysis. J Allergy Clin Immunol Pract. 2022 Nov;10(11):3047-3048.e5. doi: 10.1016/j.jaip.2022.08.040.PMID: 36357053.

Dhippayom T, Saldanha IJ, Chaiyakunapruk N, Devine B. Characterizing health services interventions for evidence synthesis by using the Theme, Intensity, Provider/Platform (TIP) Framework. J Evid Based Med. 2022;15:333-337. PMID: 36529853. doi: 10.1111/jebm.12511. Epub 2022 Dec 18.

Saldanha IJ, Adam GP, Bañez LL, Bass EB, Berliner E, Devine B, Hammarlund N, Jain A, Norris SL, Skelly AC, Vander Ley K, Wang Z, Wilt TJ, Viswanathan M. Inclusion of nonrandomized studies of interventions in systematic reviews of interventions: updated guidance from the Agency for Health Care Research and Quality Effective Health Care program. J Clin Epidemiol. 2022 Sep 19:S0895-4356(22)00217-7. doi: 10.1016/j.jclinepi.2022.08.015. Online ahead of print. PMID: 36245131. PMCID: PMC10777810.

Saldanha IJ, Skelly AC, Vander Ley K, Wang Z, Berliner E, Bass EB, Devine B, Hammarlund N, Adam GP, Duan-Porter D, Bañez LL, Jain A, Norris SL, Wilt TJ, Leas B, Siddique SM, Fiordalisi CV, Patino-Sutton C, Viswanathan M. Inclusion of Nonrandomized Studies of Interventions in Systematic Reviews of Intervention Effectiveness: An Update. Methods Guide for Comparative Effectiveness Reviews. (Prepared by the Scientific Resource Center under Contract No. 290-2017-00003-C.) AHRQ Publication No. 22-EHC033. Rockville, MD: Agency for Healthcare Research and Quality; September 2022. DOI: https://doi.org/10.23970/AHRQEPCMETHODSGUIDENRSI. PMID: 36153934. Posted final reports are located on the Effective Health Care Program search page.

Lee W, Schwartz N, Bansal S, Khor S, Hammarlund N, Basu A, Devine B. A Scoping Review of the Use of Machine Learning in Health Economics and Outcomes Research: Part 1 – Data from Wearable Devices, Value Health. 2022 Sep 15:S1098-3015(22)02145-3. PMID doi: 10.1016/j.jval.2022.08.005. Online ahead of print.: 36115806.

Lee W, Schwartz N, Bansal S, Khor S, Hammarlund N, Basu A, Devine B. A Scoping Review of the Use of Machine Learning in Health Economics and Outcomes Research: Part 2 – Data from non-Wearables. Value Health. 2022 Dec;25(12):2053-2061. PMID: 35989154. doi: 10.1016/j.jval.2022.07.011. Epub 2022 Aug 18.

Canestaro WJ, Devine B, Bansal A, Sullivan SD, Carlson JJ. Adjustment of Publication Bias Using a Cumulative Meta-Analytic Framework. Int J Technol Assess Health Care. 2022;38:e61. doi: 10.1017/S0266462322000435.PMID: 35761433.

Quach D, Jiao B, Basu A, Bender MA, Hankins J, Ramsey S, Devine B. A landscape analysis and discussion of value of gene therapies for sickle cell disease. Expert Rev Pharmacoecon Outcomes Res 2022 Apr 18:1-21. doi: 10.1080/14737167.2022.2060823. Online ahead of print. PMID: 35363602. PMCID: PMC10783332.

Baldwin Z, Jiao B, Basu A, Roth J, Bender MA, Devine B. Medical and non-medical costs of sickle cell disease, treatments, and related complications: A Systematic Review and Landscape Analysis. Pharmacoecon Open. 2022 Apr 26. doi: 10.1007/s41669-022-00330-w. Online ahead of print. PMID: 35471578

Dhippayom T, Boonpattharatthiti K, Thammathuros T, Dilokthornsakul P, Sakunrag I, Devine B. Clinical Outcomes of Different Warfarin Self-Care Strategies: A Systematic Review and Network Meta-Analysis. Thromb Haemost. 2022 Apr;122(4):492-505. doi: 10.1055/a-1677-9608. Epub 2022 Jan 20.PMID: 34695873

Lee W, Cheng S, Grant SJ, Marcum ZA, Devine B. Use of Geriatric Assessment in Cancer Clinical Trials: A Systematic Review. J Geriatric Onc. 2022;13:907.913. doi: 10.1016/j.jgo.2022.04.014. PMID: 35550351.

Dhippayom T, Saensook T, Promkhatja N, Teakthong T, Chaiyakunapruk N, Devine B. Comparative effects of music intervention on depression in older adults: A systematic review and network meta-analysis. EClinicalMedicine. 2022 Jul 1;50:101509. doi: 10.1016/j.eclinm.2022.101509. eCollection 2022 Aug.PMID: 35812990

Dhippayom T, Wateemongkollert A, Mueangfa K, Im H, Dilokthornsakul P, Devine B. Comparative efficacy of strategies to support self-management in patients with asthma: a systematic review and network meta-analysis. J Allergy Clin Immunol Pract. 2022 Mar;10(3):803-814. doi: 10.1016/j.jaip.2021.09.049. Epub 2021 Oct 18.PMID: 34673290.

Saldarriaga EM, Devine B. Lessons from a meta-analysis in the presence of statistical heterogeneity. A case study of SARS-CoV-2 detection window. Incremental Thoughts, The CHOICE Institute Student Blog. February 2022. Available at: https://choiceblog.org/2022/02/

2. Precision medicine: pharmacogenomics (n = 17) genomic risk for hereditary cancers (n = 10)

Support: NIH/National Cancer Institute, NIH/National Human Genome Research Institute (eMERGE), NIH/National Institute on Minority Health and Health Disparities (CSER);UW School of Pharmacy Innovation Award, NIH/National Library of Medicine (T15-donated)

**Devine B, Albers S, Chan HH, Jiang S, Dusic EJ, Harris, H, Shirts B, Brandt J, Swisher E, Bowen DJ. Comparative and cost-effectiveness of primary care screening strategies to identify patients at high risk of hereditary cancers. BMC Prim Care. 2025 Dec 22. doi: 10.1186/s12875-025-03137-w. Online ahead of print.

*Smith DM, Douglas MP, Aquilante CL, Dverka PA, Devine B, Dunnenberger HM, Empey PE, Hertz DL, Monte AA, Moyer AM, Patel JN, Pratt VM, Saulsberry L, Scott SA, Voora D, Woodahl EL, Whirl-Carrillo M, Oni-Orisan A. Progress in Pharmacogenomics Implementation in the U.S.: Barrier Erosion and Remaining Challenges. Clin Pharmacol Ther. 2025 Oct;118(4):778-789. doi: 10.1002/cpt.3736. Epub 2025 Jun 4. PMID: 40468601.

**Swisher EM, Harris HM, Knerr S, Theoryn TN, Norquist BM, Brant JM, Shirts BH, Beers F, Cameron D, Dusic EJ, Reinmann LA, Devine B, Raff ML, Kadel R, Cabral HW, Wang C. Strategies to Assess Risk for Hereditary Cancer in Primary Care Clinics: A Cluster Randomized Clinical Trial. JAMA Netw Open. 2025 Mar 3;8(3):e250185. doi: 10.1001/jamanetworkopen.2025.0185.PMID: 40053353.

**Gilmore MJ, Knerr S, Kraft SA, Bulkley JE, Biesecker BB, Feigelson HS, Huner JE, Jenkins CL, Kauffman TL, Lee SS, Liles EG, Mittendorf KF, Muessig KR, Porter KM, Rolf BA, Rope AF, Zepp JM, Anderson KP, Devine B, Joseph G, Leo MC, Goddard K, Wilfond BS. Improving care for marginalized populations at risk for hereditary cancer syndromes: Innovations that expanded reach in the CHARM study. Public Health Genomics. 2024;27(16-22. doi: 10.1159/000535610. Epub 2023 Dec 23. PMID: 38142673.

**Guo B, Knerr S, Kauffman TL, Mittendorf KF, Keast E, Gilmore MJ, Feigelson HS, Lynch FL, Muessig KR, Okuyama S, Zepp JM, Veenstra DL, Hsu L, Phipps A, Lindstrom S, Leo MC, Goddard KAB, Wilfond BS, Devine B. Risk management actions following genetic testing in the Cancer Health Assessments Reaching Many (CHARM) Study: A prospective cohort study. Cancer Med. 2023 Sep;12(18):19112-19125. PMID: 37644850. doi: 10.1002/cam4.6485. Epub 2023 Aug 30.

*David SP, Devine B, Palaniappan L, Houwink EJ. Editorial: State of the science of pharmacogenomics implementation in healthcare systems and communities. Front Pharmacol. 2024;15:1463384. doi: 10.3389/fphar.2024.1463384. eCollection 2024. PubMed PMID: 39114360; PubMed Central PMCID: PMC11303329.

***Knerr , Guyo B, Wernli KJ, Mittendorf K, Feigelson HS, Gilmore MJ, Jarvik G, Kauffman TL, Keast EM, Liles B, Lynch F, Muessig K, Okuyama S, Veenstra DL, Zepp J, Wilfond BS, Devine B, Goddard K. Longitudinal Adherence to Breast Cancer Surveillance Following Cancer Genetic Testing in an Integrated Health Care System. Breast Cancer Research and Treatment. 2023;201:461–470. https://doi.org/10.1007/s10549-023-07007-w-

**Linder JE, Allworth A, Bland ST…Devine B,… et al. for the eMERGE Consortium. Returning integrated genomic risk and clinical recommendations: the eMERGE study. Genet Med. 2023 Apr;25(4):100006. doi: 10.1016/j.gim.2023.100006. Epub 2023 Jan 6.

*Devine EB, Boyce R, Wiisanen K (eds). Clinical Decision Support for Pharmacogenomic Precision Medicine: Foundations and Implementation. Elsevier, 2022. ISBN 978-0-12-824-453-1.

*Boyce RD, Camacho J, Liang W, Wiisanen K, Devine B. Overview of effective pharmacogenomic clinical decision support In: Devine EB, Boyce R, Wiisanen K (eds). Clinical Decision Support for Pharmacogenomic Precision Medicine. Elsevier, 2022. ISBN 978-0-12-824-453-1.

**Angelo F, Veenstra D, Knerr S, Devine B. Prevalence and prediction of medical distrust in a diverse medical genomic research sample. Genet Med. 2022 Jul;24(7):1459-1467. doi: 10.1016/j.gim.2022.03.007. Epub 2022 Apr 6. PubMed PMID: 35384843.

**Knerr S, Guo B, Mittendorf KF, Goddard KAB, Devine EB and the CHARM Study Team. Risk-reducing surgery in unaffected women receiving cancer genetic testing in an integrated healthcare system. Cancer 2022;128:3090-3098. doi: 10.1002/cncr.34349. Online ahead of print. PMID: 35679147.

*Chaitesipaseut L, Wilson Norton J, Trivelli K, Argon S, Petrie I, Ragueneau‐Majlessi I, Mikes T, Nguyen H, Devine B. Evaluating the feasibility of performing pharmacogenetic guided‐medication therapy management in a retirement community: A prospective, single arm study. Journal of the American College of Clinical Pharmacy. 2022 Mar;5(3):291-301. https://doi.org/10.1002/jac5.1570.

**Phillips KA, Trosman JR, Douglas MP, Devine BE, et al. US Private Payers’ Perspectives on Insurance Coverage for Genome Sequencing Versus Exome Sequencing: A Study by the Clinical Sequencing Evidence-Generating Research Consortium (CSER). Genet Med 2022;24:238-244.

3. Health technology assessment and outcomes research including preference-based methods, discrete choice experiments and multi-criteria decision analysis. (n-31)

Support: AHRQ, NIH/National Heart, Lung, and Blood Institute, Patient-Centered Outcomes Research Institute, US Veterans Affairs, UW Health Tech Fund, AHRQ T-32 (donated), pharmaceutical industry

Basu A, Winn AN, Johnson KM, Jiao B, Devine B, Hankins JS, Arnold SD, Bender MA, Ramsey SD. Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness Analysis. Ann Intern Med. 2024 Feb;177(2):155-164. doi: 10.7326/M23-1520. Epub 2024 Jan 23. PubMed PMID: 38252942; PubMed Central PMCID: PMC11657757.

Basu A, Veenstra DL, Devine B, Carlson JJ, Sullivan SD. Medicare drug price negotiations: A principles/based guide for CMS. Health Affairs Forefront, June 22, 2023. Available at: https://www.healthaffairs.org/content/forefront/medicare-drug-price-negotiations-principles-based-guide-cms. Accessed: 26 July 2023.

Sullivan SD, Lakdawalla DN, Devine B, Grueger J, Garrison LP, Carlson JJ, Veenstra DL, Phelps CE, Basu A. Alternatives to the QALY for comparative effectiveness research. Health Affairs Forefront, April 21, 2023. Available at: https://www.healthaffairs.org/content/forefront/alternatives-qaly-comparative-effectiveness-research. Accessed: 26 July 2023.

Poehler D, Czerniecki J, Norvell D, Henderson A, Dolan J, Devine B. A multi-criteria decision analysis to compare patient and provider preferences for lower limb amputations. Ann Vasc Surg. 2023 May 30:S0890-5096(23)00284-4. doi: 10.1016/j.avsg.2023.05.026. Online ahead of print. (part of Special Issue: Original Work by Women). PMCID: PMC10782550.

Poehler D, Czerniecki J, Norvell D, Henderson A, Dolan J, Devine B. The Development and Pilot Study of a Multiple Criteria Decision Analysis (MCDA) to Compare Patient and Provider Priorities around Amputation-Level Outcomes. MDM Policy & Practice. 2022;7(2). PMCID: PMC9761219. doi:10.1177/23814683221143765.

Bounthavong M, Christopher MLD, Veenstra DL, Basu A, Devine EB. Exploring Providers' Perception to Naloxone Education for Opioid Overdose After Receiving Academic Detailing at the U.S. Department of Veterans Affairs. J Pharm Pract. 2023 Jun;36(3):514-522. doi: 10.1177/08971900211053282. Epub 2021 Nov 12. PubMed PMID: 34766510.

Saldarriaga EM, Hauber B, Carlson JJ, Barthold D, Veenstra DL, Devine, B. Assessing payers’ preferences for real world evidence: A discrete choice experiment. Value Health. 2022 Mar;25(3):443-450. doi: 10.1016/j.jval.2021.09.016. Epub 2021 Oct 30. PubMed PMID: 35227457. (Editor´s Choice)

Johnson KM, Jiao B, Bender MA, Ramsey SD, Devine B, Basu A. Development of a conceptual model for evaluating new non-curative and curative therapies for sickle cell disease. PLoS One. 2022 Apr 28;17(4):e0267448. doi: 10.1371/journal.pone.0267448. eCollection 2022.PMID: 35482721

4. Comparative effectiveness research in the context of clinical informatics. (n=10)

Support: AHRQ, Pharmaceutical Research and Manufacturers Association Foundation Comparative Effectiveness Research Program

Devine EB, Perfetto E, Pickard AS, Schumock GT, Segal JB, Brixner D, Cannon E, Gagnon JP, Garrison LP, Murray, MD. Nine Years of Comparative Effectiveness Research Education and Training: Initiative Supported by the PhRMA Foundation. J. Comp. Eff. Res. 2018;7:167-175. PMID: 29464964. doi: 10.2217/cer-2017-0059. Epub 2018 Feb 21.

Devine EB, Van Eaton E, Zadworny ME, Symons R, Devlin A, Yanez D, Yetisgen M, Keyloun KR, Capurro D, Alfonso-Cristancho R, Flum DR, Tarczy-Hornoch P. Automating Electronic Clinical Data Capture for Quality Improvement and Research: The CERTAIN Validation Project of Real World Evidence. .EGEMS (Wash DC). 2018 May 22;6(1):8. doi: 10.5334/egems.211.PMID: 29881766.

Edwards T, Lavallee D, Clowes A, Devine EB, Flum DR, Meissner M, Thomason ET, Barbic SP, Beck SJ, Patrick DL. Preliminary Validation of the Claudication Symptom Instrument (CSI). Vascular Medicine, 2017, 1–8. DOI: 10.1177/1358863X17731623. PubMed PMID: 28931345.

Devine B. Concordium 2016: Data and Knowledge Transforming Health. EGEMS (Wash DC). 2017 Apr 20;5(2):9. doi: 10.13063/2327-9214.1306. PubMed PMID: 29881751; PubMed Central PMCID: PMC5983075.

Devine EB, Alfonso-Cristancho R, Yanez ND, Edwards TC, Patrick DL, Armstrong CAL, Devlin A, Symons RG, Meissner MH, Thomason EL, Lavallee DC, Kessler LG, Flum DR, and CERTAIN Collaborative. Patient-Reported Outcomes after Medical versus Revascularization Interventions for Intermittent Leg Claudication. JAMA Surg. 2016 Oct 19;151(10):e162024. doi: 10.1001/jamasurg.2016.2024. PubMed PMID: 27760274.

Puttkammer N, Baseman JG, Devine EB, Valles MPJS, Hyppolite N, Garilus F, Honore JG, Matheson AI, Sherr K, Yuhas K, Zeliadt S, Cadet JR, Zamor G, Pierre E, Barnhart S. An assessment of data quality in a multi-site electronic medical record system in Haiti. Int J Med Inform. 2016 Feb;86:104-16. doi: 10.1016/j.ijmedinf.2015.11.003. Epub 2015 Nov 17. PMID: 26620698.

Van Eaton EG, Devlin AB, Devine EB, Flum DR, Tarczy-Hornoch P. Achieving and sustaining automated health data linkages for learning systems: barriers and solutions. EGEMS (Wash DC). 2014 Jul 24;2(2):1069. doi: 10.13063/2327-9214.1069. eCollection 2014.PMID: 25848606.

Flum DR, Alfonso-Cristancho R, Devine EB, Devlin A, Farrokhi ET, Tarczy-Hornoch P, Kessler L, Lavallee D, Patrick DL, Gore JL, Sullivan SD, for the CERTAIN Collaborative. Implementation of a “Real World” Learning Healthcare System: Washington State’s Comparative Effectiveness Research Translation Network (CERTAIN). Surgery. 2014 May;155(5):860-6. DOI: 10.1016/j.surg.2014.01.004. PMID: 24787113.

Devine, EB, Capurro D, van Eaton E, Alfonso-Cristancho R, Devlin A, Yanez ND, Yetisgen-Yildiz M, Flum DR, Tarczy-Hornoch P. Preparing Electronic Clinical Data for Quality Improvement and Comparative Effectiveness Research: The SCOAP CERTAIN Automation and Validation Project. EGEMS (Wash DC). 2013 Sep 10;1(1):1025. doi: 10.13063/2327-9214.1025. eCollection 2013.PMID: 25848565.

Devine EB, Edwards T, Patrick DL, Alfonso-Cristancho R, Yanez ND, Devlin A, Symons R, Flum DR, for the SCOAP CERTAIN Corporate Authorship. A Model for Incorporating Patient and Stakeholder Voices in a Learning Healthcare Network: Washington State’s Comparative Effectiveness Research Translation Network (CERTAIN). J Clin Epidemiol. 2013 Aug;66(8 Suppl):S122-9. doi: 10.1016/j.jclinepi.2013.04.007. PMID: 23849146.

Research Program Summary

5.Medication safety (n=14)

Support: AHRQ, Merck Foundation, American Society of Health-System Pharmacists, UW Royalty Research Fund

Slade IR, Beck SJ, Kramer CB, Symons RG, Cusumano M, Flum DR, Gallagher TH, Devine EB. Communication Training, Adverse Events, and Quality Measures: 2 Retrospective Database Analyses in Washington State Hospitals. J Patient Saf. 2021 Aug 1;17(5):e393-e400. doi: 10.1097/PTS.0000000000000348. PubMed PMID: 28671907.

Devine EB. The Value of Computerized Provider Order Entry: Is It time for the debate to be over? Jt Comm J Qual Patient Saf. 2015;41(8):339-40. PMID: 26215522.

Forrester S, Hepp Z, Roth J. Wirtz HS, Devine EB. Cost-effectiveness of a computerized provider order entry system in improving medication safety in ambulatory care. Value Health. 2014 Jun;17(4):340-9. DOI: 10.1016/j.jval.2014.01.009. Epub 2014 May 5. NIHMS ID: NIHMS 567912. PMID: 24968993

Lau B, Overby CL, Wirtz HS, Devine EB. Use of a clinical decision support tool in the ambulatory setting to improve adherence to national monitoring guidelines for medication-laboratory tests. Appl Clin Inf 2013; 4. DOI:10.4338/ACI-2013-06-RA-0041. PMC3885910. PMID: 24454577

Devine EB, Patel R, Dixon DR, Sullivan SD. Assessing attitudes toward electronic prescribing adoption in primary care: a survey of prescribers and staff. Inform Prim Care 2010;18(3):177-87 PMID: 21396241. PubMed PMID: 21396241.

Devine EB, Williams EC, Martin DP, Sittig DF, Tarczy-Hornoch P, Payne TH, Sullivan SD. Prescriber and staff perceptions of an electronic prescribing system in primary care: a qualitative assessment. BMC Med Inform Decis Mak. 2010 Nov 19;10:72. doi: 10.1186/1472-6947-10-72. PMID: 21087524.

Devine EB, Hansen RN, Wilson-Norton JL, Lawless NM, Fisk AW, Blough DK, Martin DP, Sullivan SD. The impact of computerized provider order entry on medication errors in a multispecialty group practice. J Am Med Inform Assoc. 2010 Jan-Feb;17(1):78-84. doi: 10.1197/jamia.M3285. PMID: 20064806.

Devine EB, Hollingworth W, Hansen RN, Lawless NM, Wilson-Norton JL, Martin DP, Blough DK, Sullivan SD. Electronic prescribing at the point of care: A time-motion study in the primary care setting. Health Serv Res. 2010 Feb;45(1):152-71. doi: 10.1111/j.1475-6773.2009.01063.x. Epub 2009 Nov 19. PMID: 19929963.

Devine B. Bad writing, wrong medication [Spotlight]. AHRQ WebM&M [serial online]. April 2010. Available at: http://www.webmm.ahrq.gov/case.aspx?caseID=215

Devine EB, Wilson-Norton JL, Lawless NM, Hansen RN, Hollingworth W, Fisk AW, Sullivan SD. Implementing an ambulatory e-prescribing system: strategies employed and lessons learned to minimize unintended consequences. In: Henriksen K, Battles JB, Keyes MA, Grady ML, editors. Advances in patient safety: New directions and alternative approaches. Vol. 4. Technology and Medication Safety. AHRQ Publication No. 08-0034-4. Rockville, MD: Agency for Healthcare Research and Quality; August 2008. PMID:21249960.

Devine EB, Wilson-Norton JL, Lawless NM, Hansen RN, Haney KK, Fisk AW, Sullivan SD. The impact of an ambulatory CPOE system on medication errors. AMIA Annu Symp Proc. 2008 Nov 6:928. PMID: 18999201.

Hollingworth W, Devine EB, Hansen RN, Lawless NM, Comstock BA, Wilson-Norton JL, Tharp KL, Sullivan SD. The impact of e-prescribing on prescriber and staff time in ambulatory care clinics: A time-motion study. J Am Med Inform Assoc. 2007 Nov-Dec;14(6):722-30. Epub 2007 Aug 21. PMID:17712088.

Devine EB, Wilson-Norton JL, Lawless NM, Hansen RN, Hazlet TK, Kelly K, Hollingworth W, Blough DK, Sullivan SD. Characterization of prescribing errors in an internal medicine clinic. Am J Health Syst Pharm. 2007 May 15;64(10):1062-70. PMID:17494906

Devine EB, Wilson-Norton JL, Lawless NM, Hazlet TK, Hansen R, Kelly K, Te S, Wong C. Preparing for Ambulatory Computerized Prescriber Order Entry by Evaluating Preimplementation Medication Errors. In: Henriksen K, Battles JB, Mark ES, Lewin DI, eds. Advances in patient safety: from research to implementation. Vol. 2, Concepts and methodology. AHRQ Publication No. 05-0021-2. Rockville, MD: Agency for Healthcare Research and Quality; Feb. 2005 PMID:21249833. PMID: 21249833.

6. Real world evidence of costs and outcomes (n=24)

Support: NHLBI, US Fulbright Program, pharmaceutical industry

Kim JR, Park TJ, Agapova M, Blumenfeld A, Smith JH, Shah D, Devine B. Healthcare Resource Use and Costs Associated with the Misdiagnosis of Migraine. Headache. 2025 Jan;65(1):35-44. doi: 10.1111/head.14822. Epub 2024 Aug 28. PMID: 39193981.

Park TJ, Hansen R, Gillard P, Shah D, Ferguson WG, Piccini J, Romano MA, Devine B. Healthcare resource utilization and costs for patients with postoperative atrial fibrillation in the United States. J Med Econ, 2023;26:1, 1417-1423, PMID: 37801391. DOI: 10.1080/13696998.2023.2267390.

De la Cruz-Sánchez E, Moreno-Llamas A,, García-Mayor J, Mendiola-Olivares J, Torres-Cantero A, Devine B. Estimating the association between Covid-19 sources of information, beliefs, and vaccination rates: Results from an EU-wide survey. Eur J Public Health. 2023 33:897-904. PMID: 37459132. doi: 10.1093/eurpub/ckad115.

Ramsey SD, Bender MA, Li L, Johnson KM, Jiao B, Devine B, et al. (2022) Prevalence of comorbidities associated with sickle cell disease among non-elderly individuals with commercial insurance–A retrospective cohort study. PLoS ONE 17(11): e0278137. https://doi.org/10.1371/journal.pone.0278137.

Johnson KM, Jiao B, Ramsey SD, Bender MA, Devine B, Basu A. Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance. Blood Adv. 2023 Feb 14;7(3):365-374. doi: 10.1182/bloodadvances.2021006281. PubMed PMID: 35575558; PubMed Central PMCID: PMC9898623.

Positions

Current Primary Academic Appointment
Professor Emerita, The Comparative Health Outcomes, Policy and Economics (CHOICE) Institute

School of Pharmacy, University of Washington

External Academic Appointments

2024 - 2026 Visiting Professor, Population Health Sciences, Bristol Medical School, University of Bristol, UK

2022 - 2023 Honorary Professor, Epidemiology, Public Health & Health Services, School of Medicine, University of Murcia, Spain

2021 – 2022 Visiting Professor, Epidemiology, Public Health & Health Services, School of Medicine, University of Murcia, Spain

2021 Fulbright Scholar, Epidemiology, Public Health & Health Services, School of Medicine, University of Murcia, Spain

Adjunct Academic Appointments

2009 - 2023 Adjunct Professor, Department of Biomedical Informatics & Medical Education, School of Medicine

2012- 2023 Adjunct Professor, Department of Health-Systems and Population Health (Health Services), School of Public Health

2012-2019 Adjunct Associate Professor/Professor, Department of Surgery, School of Medicine

2018- Member, Plein Center for Aging, School of Pharmacy

2016- Member, Institute for Public Health Genetics, School of Public Health

Administrative Academic Appointments

University of Washington, School of Pharmacy

2022 - 2024 Associate Director, The CHOICE Institute

2015 - 2022 Director, Graduate Program, The CHOICE Institute

2015 - 2022 Associate Director, Agency for Healthcare Research and Quality (AHRQ) T-32 Training Grant Health Services

2014 - 2025 Assistant Director, Pacific Northwest Evidence-based Practice Center (AHRQ-funded)

2012 - 2023 Director, UW CHOICE Allergan Fellowship Program

Positions

Education and Training

Education & Training

2025

MSc, Medical Statistics and Health Data Science, School of Medicine, University of Bristol, UK

Dissertation: “The impact on results when causal inference studies and bias-adjustment procedures are incorporated into network meta-analyses of randomized controlled trials”

2008

PhD, Health Services Research, Dept of Health Services, School of Public Health, UW, Seattle WA Dissertation: “Evaluating the impact of an ambulatory computerized provider order entry system on outcomes in a community-based multispecialty health system”

2001

Post-doctoral Fellowship in Pharmacoeconomics and Outcomes Research, UW, Seattle, WA and Roche Global Pharmacoeconomics, Palo Alto, CA

1999

Master in Business Administration, University of San Francisco, San Francisco, CA

Thesis: “UCSF Pharmacy Faculty Practice Consortium: A plan for optimizing medication use in physician group practices”

1979

Clinical Pharmacy Residency, Veterans Administration Health Care System, Palo Alto, CA

1978

Doctor of Pharmacy degree, University of the Pacific, Stockton, CA

1975

Pre-pharmacy & Music minor, Conservatory of Music, University of the Pacific, Stockton, CA

Teaching

I teach methods courses on the UW Health Sciences campus.

2024 - UW CHOICE: Certificate in Data Science in Health Economics and Outcomes Research

(non-matriculated graduate-level distance learning)

2015 - UW CHOICE: Certificate in Health Economics and Outcomes Research, Market Access, and Health Technology Assessment (non-matriculated graduate-level distance learning)

2013-2023 UW Health Sciences: Assessing Outcomes in Health and Medicine (PhD students; clinical fellows)

2014-2016 UW Health Sciences: Intermediate Meta-Analysis (PhD, MS, clinical fellows, and PharmD students).

2011-2023 UW School of Pharmacy: Fundamentals of biostatistics and epidemiology to facilitate critical literature evaluation (Doctor of Pharmacy students)

2008-2009 UW School of Pharmacy: Evidence-based Medicine (Doctor of Pharmacy students).

Teaching

Contact